Jpmorgan Chase & CO Taro Pharmaceutical Industries LTD Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Dec 26, 2024
BUY
$40.97 - $43.33 $511,182 - $540,628
12,477 New
12,477 $528,000
Q1 2024

May 10, 2024
BUY
$40.97 - $43.33 $251,023 - $265,482
6,127 Added 96.49%
12,477 $528,000
Q4 2023

Dec 26, 2024
BUY
$32.77 - $42.31 $208,089 - $268,668
6,350 New
6,350 $265,000
Q4 2023

Feb 12, 2024
SELL
$32.77 - $42.31 $2,064 - $2,665
-63 Reduced 0.98%
6,350 $265,000
Q3 2023

Nov 14, 2023
SELL
$35.46 - $40.13 $10,815 - $12,239
-305 Reduced 4.54%
6,413 $241,000
Q2 2023

Aug 11, 2023
BUY
$24.24 - $40.97 $133,223 - $225,171
5,496 Added 449.75%
6,718 $254,000
Q1 2023

May 11, 2023
BUY
$23.0 - $31.59 $7,015 - $9,634
305 Added 33.26%
1,222 $29,000
Q4 2022

Feb 13, 2023
SELL
$27.6 - $32.99 $3,864 - $4,618
-140 Reduced 13.25%
917 $26,000
Q3 2022

Nov 14, 2022
SELL
$28.74 - $39.9 $65,613 - $91,091
-2,283 Reduced 68.35%
1,057 $31,000
Q2 2022

Aug 11, 2022
BUY
$35.0 - $43.59 $88,305 - $109,977
2,523 Added 308.81%
3,340 $121,000
Q1 2022

May 11, 2022
SELL
$43.12 - $50.3 $137,035 - $159,853
-3,178 Reduced 79.55%
817 $35,000
Q4 2021

Feb 10, 2022
SELL
$47.6 - $65.0 $419,165 - $572,390
-8,806 Reduced 68.79%
3,995 $200,000
Q3 2021

Nov 12, 2021
BUY
$62.34 - $73.38 $798,014 - $939,337
12,801 New
12,801 $815,000

Others Institutions Holding TARO

# of Institutions
7
Shares Held
16.8K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email